Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity

Detalles Bibliográficos
Autores principales: Fraunhoffer, Nicolas Alejandro, Abuelafia, Analía Meilerman, Chanez, Brice, Bigonnet, Martin, Gayet, Odile, Roques, Julie, Chuluyan, Eduardo, Dusetti, Nelson, Iovanna, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648386/
https://www.ncbi.nlm.nih.gov/pubmed/36178036
http://dx.doi.org/10.1002/cac2.12365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648386/
https://www.ncbi.nlm.nih.gov/pubmed/36178036
http://dx.doi.org/10.1002/cac2.12365

Ejemplares similares